ARCHIVES

Phase II Study Of Pfizer Drug Meets Primary Endpoint

This article is from The Cancer Letter archive.

Vol. 32 No. 4 | April 24, 2009

Download PDF Visit The Full Archive

Related Articles

Leukemia Society Seeks Applicants for Grants

December 9, 1994

In The Courts: Lilly’s Claims Figured In Scripts Written To Coach Sales res, Court Documents Show

July 30, 1999

In Brief: CFO Dwain Morris to Leave MD Anderson Cancer Center

May 2, 2014

Sarcoma Survivors At Risk Of Blood Clots, Study Finds

May 25, 2007

Carcinogenicity Test For Cis-Platinum Needed, DCT Says, But Declines To Pay For It

June 16, 1978

Treatment Progress Stirs Up Big ASCO turnout; Reports Presented

May 14, 1976